Skip to main content
. 2020 Jun 4;7(7):1132–1140. doi: 10.1002/acn3.51076

Table 6.

Percentages of all patients with neurological presentations diagnosed using each investigation, in the inpatient and outpatient setting.

Investigation

Outpatients:

(n = 53)

Inpatients:

(n = 111)

WES 13 (24%) 12 (11%)
Microarray 8 (15%) 10 (9%)
MRI 2 (4%) 39 (35%)
Metabolic screening 1 (2%) 8 (7%)
Genetic panel 3 (7%) 6 (5%)
Targeted gene 1 (2%) 1 (1%)
Negative WES 1 (2%) 4 (4%)
Pending results or no other testing sent 24 (45%) 31 (28%)